Related Experiment Video
Updated: Aug 31, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
The impact of cerebrovascular lesions in Alzheimer disease--a comparative autopsy study
Kurt A Jellinger1, Erich Mitter-Ferstl
1Institute of Clinical Neurobiology, Kenyongasse 18, 1070 Vienna, Austria. kurt.jellinger@univie.ac.at
Insights
Alzheimer disease (AD) brains show significantly more cerebrovascular lesions, including infarcts and hemorrhages, than control brains. This suggests a higher risk of stroke in individuals with AD.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Cerebrovascular Diseases
Background:
- Epidemiological and clinico-pathological data suggest overlaps between Alzheimer disease (AD) and cerebrovascular pathology.
- Previous studies on the relationship between AD and cerebrovascular lesions have yielded controversial results.
Purpose of the Study:
- To compare the frequency of cerebral infarcts, hemorrhages, and minor cerebrovascular lesions in autopsy-proven Alzheimer disease (AD) cases versus age-matched controls.
Main Methods:
- Comparison of 730 autopsy-proven AD cases with 535 age-matched controls.
- Utilized routine and immunohistochemical methods for pathological assessment.
Main Results:
- Cerebrovascular pathology was significantly more prevalent in AD brains (48.0%) compared to controls (32.8%).
- Minor to moderate lesions (lacunes, amyloid angiopathy) and severe lesions (infarcts, hemorrhages) were more frequent in AD.
- Acute and old cerebral hemorrhages correlated significantly with severe amyloid angiopathy.
Conclusions:
- The study indicates a higher incidence of cerebrovascular lesions in Alzheimer disease (AD).
- Individuals with AD may have greater susceptibility to stroke.
- Further prospective clinicopathological studies are warranted to confirm these findings.
Background:
Recent epidemiological and clinico-pathological data suggest overlaps and some synergistic effects between Alzheimer disease (AD) and cerebrovascular pathology, but the results of studies of the relationship between the two types of lesion have been controversial.
Objective:
Comparison of the frequency of cerebral infarcts, hemorrhages and minor cerebrovascular lesions in AD and age-matched control brains.
Subjects And Methods:
730 consecutive cases of autopsy-proven AD and 535 age-matched controls were compared using current routine and immunohistochemical methods. Results The total prevalence of cerebrovascular pathology in AD was significantly higher than in controls (48.0 vs 32.8%, p<0.01). Minor to moderate cerebrovascular lesions (lacunes, amyloid angiopathy with and without minor vascular lesions) were more frequent in AD than in controls (31.6 vs 23.4 %), the frequency of severe vascular pathology (old and recent infarcts and hemorrhages) in AD was significantly higher than in controls (16.7 % and 7.4 % vs 2.1% and 3.2%, respectively, p<0.01). There was no correlation between the severity of cerebral amyloid angiopathy with minor to severe subcortical lacunes and Ammon's horn sclerosis or to acute and old ischemic infarcts. On the other hand, acute and old cerebral hemorrhages were significantly correlated with severe amyloid angiopathy. The brain weight and severity of cognitive decline did not correspond to the degree of vascular pathology, but higher neuritic Braak scores and reduced brain weight contributed to the production of cognitive impairment.
Conclusion:
In accordance with previous findings in AD and in Parkinson disease, our data indicate a higher incidence of cerebrovascular lesions and greater susceptibility to death from stroke in AD in the population studied, but further prospective clinicopathological studies are warranted.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

